ECTTA, ESC & ERS Specialty Update Symposium
SUNDAY 24 SEPTEMBER | 09:00-12.50
SESSION 1 - ECTTA & ERS joint session - To provide insights in key features of lung transplantation
CHAIRS : Arne Neyrinck, Leuven, Belgium
Robin Vos, Leuven, Belgium
09:00 How to personalise CLAD management
Robin Vos, Leuven, Belgium
09:20 Can LAS survive in Europe
Jens Gottlieb, Hannover, Germany
09:40 Should we move from ventilation to awake ECMO?
Alexis Slama, Vienna, Austria
10:00 Is EVLP a tool for immunoregulation?
James Fildes, Manchester, United Kingdom
10:20 How extended is my donor?
Christian Benden, Zurich, Switzerland
10.40–11.00 Break
SESSION 2 - ECTTA & ESC joint session - Advanced heart failure - when drugs alone are not enough: a case-based approach
CHAIRS : Sharon Hunt, Palo Alto, United States
Luciano Potena, Bologna, Italy
11.00 The patient sliding on inotropes: is my patient too frail to recover after VAD or transplant?
Peter Macdonald, Darlinghurst, Australia
11.20 Right ventricular failure: LVAD, temporary RVAD or BiVAD?
Arjang Ruhparwar, Heidelberg, Germany
11.40 When to refer a patient for heart transplant or LVAD: a stepwise approach
Kristjan Karason, Gothenburg, Sweden
12.00 Palliation and end of life care in end-stage heart failure
James Beattie, London, United Kingdom
______________________________________________________________________________________________________
OBJECTIVES | To provide updates on the etiologies, mechanisms, treatment strategies and diagnostic tools of early and late dysfunction of the transplanted heart and lungs. The lectures will focus on the main strategies and mechanisms leading to graft dysfunction starting from donor and organ management, to prevention of long-term chronic immunological injury leading to graft impairment.
TARGET AUDIENCE |Cardiologist, Pneumologists, Cardio-thoracic surgeons, Anestesiologists, Transplant coordinators.
______________________________________________________________________________________________________
The European Cardio Thoracic Transplant Association has been endorsed to promote initiatives aimed at improving the educational and scientific opportunities ESOT can offer to professionals involved in heart and lung transplantation
GOALS |Our ambition is to become a gathering home to foster scientific growth, exchange programs, collaborative projects and funding opportunities dedicated to European heart and lung transplantation programs.
AIM |Improve quality of care for patients with end-stage heart or lung disease and for thoracic organ transplant recipients. Advance education and stimulate networking amongst thoracic transplant professionals.